Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production - Wikidata - awgldk - TriplyDB

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

http://www.wikidata.org/entity/Q38754093

about

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study.Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.SOCS Proteins in Macrophage Polarization and Function.Immune cell profile of dental pulp tissue treated with zoledronic acid.Zoledronate as effective treatment for minimal trauma fractures in a child with STAT3 deficiency and osteonecrosis of the hip.IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats.The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.Zoledronic acid exacerbates inflammation through M1 macrophage polarization.Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials Zoledronic Acid Elicits Proinflammatory Cytokine Profile in Osteolytic Prostate Cancer Cells

P2860

Q28603645-F0986266-B509-4F30-9BB5-FD5FC5F1473E Q36253554-1CB68A3F-61C8-42A8-8BCA-951FC7C0EAF1 Q37087037-BF6C73FA-D794-4C49-B98B-C719C34B3826 Q38239660-1BD6A2E8-CFCB-4711-A1FB-86452BCE9815 Q39098260-975BECB7-4C92-4804-9735-82DF6D4FB8ED Q40613636-D77D8D47-2BDB-43D0-9E46-68EF52B7D89D Q41426868-4B1749C3-1AFD-4382-8D3C-ECAC24DA6D1A Q41928631-56BD04FE-902C-4CFE-8321-16452E18C30A Q42438761-63443D06-39D8-45DB-8271-6F73A5F234C5 Q48136878-0B2420B6-0110-4B07-9A11-2BCA2866A383 Q53164170-31B666AC-5C4A-470A-81C4-CB88B57BA36E Q55453523-C77A2C7A-D9F5-45F6-8461-A1FA18E3A081 Q58791940-C38D7094-F116-41CE-837F-6516EC5B6E69 Q59047122-5DE07469-5ABD-4227-9B22-104FB0AE34F7

P2860

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

http://www.wikidata.org/entity/Q38754093

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

@en

type

label

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

@en

prefLabel

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

@en

P1433

Q38754093-DF052FB5-2606-409D-8DFE-61F3FEDB4CF9

P1476

Q38754093-2A219B98-774D-4CDF-A44F-FB507CC2A007

P2093

Q38754093-07125323-7FD3-4BF0-BAB3-761ACDDFFD8A

Q38754093-BE429F62-835C-472F-8C9C-5E8657FA6815

P2860

Q38754093-0385BE36-CB37-4655-985F-F4547356BCCE

Q38754093-09647B16-AE80-42B1-9EAC-D70B0E8BD02A

Q38754093-20774AB5-7CAC-409C-9C08-A07B94B44475

Q38754093-20D98D1E-4774-4446-B503-0251BF926EF2

Q38754093-2BEF5B96-953E-4ECC-B040-954B46B1ED33

Q38754093-2D2022BB-48C0-49C4-9D37-7EFBC36A09F9

Q38754093-2DFEA5CE-A379-4513-BC64-B95AD38B4616

Q38754093-337F9F4F-6A41-4371-9018-C3511E51F0D0

Q38754093-3CC12F1F-3D56-426E-B11C-37EE462661CC

Q38754093-3D79AC7D-2DDD-4A95-8622-6C6B1A33DAA4

P304

Q38754093-7B946CE7-2EBB-44B5-B2A9-2D914924C251

P31

Q38754093-7E6B0839-DC88-43B1-93D0-23FE751D0E40

P356

Q38754093-6260BD87-3A55-4B4D-B410-9DF384310CD8

P433

Q38754093-5050349E-4D1F-4F2F-A5F5-B716AA9DAF63

P478

Q38754093-182212FC-D0F3-47FF-AC9A-F494AE5768EE

P50

Q38754093-3A7245C9-0AC3-4CEE-96C4-DEFCA77A7160

Q38754093-EC2B6573-1536-48A3-A48C-0D5596F6ABCF

P577

Q38754093-C8EFCEAB-8051-48B7-8611-53479C5BA1FB

P5875

Q38754093-BFBEDDE8-8E84-4506-AEBD-DB0E74C1D077

P698

Q38754093-5A201AF7-A5C2-4E73-AED0-E34C70199717

P932

Q38754093-E3A85D6B-45F2-4EC0-802F-E73235E50F5B

P356

P1433

Journal of Cellular Biochemistry

P1476

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

@en

P2093

Jayne S Reuben

http://www.w3.org/2001/XMLSchema#string

Paul H Krebsbach

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoimmunology: interactions of the bone and immune system

STAT3 signalling is required for leptin regulation of energy balance but not reproduction

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Differential injury responses in oral mucosal and cutaneous wounds.

Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis.

Is obesity an inflammatory condition?

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.

P304

3364-3372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.23267

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Erica L. Scheller

Kurt D. Hankenson

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51487680

http://www.w3.org/2001/XMLSchema#string

P698

21751240

http://www.w3.org/2001/XMLSchema#string

P932

3196771

http://www.w3.org/2001/XMLSchema#string